The International Veterinary Vaccinology Network's 2020 Annual Report is out now
Become a member of the International Veterinary Vaccinology Network
The Network provides the opportunity to establish multi-partnered, international collaborations that bring together the diverse skills that can accelerate the development of vaccines.
News from our members related to COVID-19 vaccine development, as well as a collection of useful publications, articles, trackers, webinars and other resources.
The IVVN fund pump-priming projects to accelerate the development of vaccines for livestock diseases of importance in LMICs. Find out more about the ten exciting projects we have funded so far.
The IVVN African Schools Outreach Programme is a collaborative initiative which trains and supports women scientists working in Africa to deliver schools outreach workshops and inspire the next generation of African scientists.
A vaccine is the most effective and safest way of ending the COVID-19 pandemic. But which vaccine types are being tested and how far have the projects progressed?
We spoke with Dr Volker Gerdts, Director and CEO of VIDO-InterVac, about his organisation’s work on developing and testing a subunit vaccine against SARS-CoV-2.
Dr Michael James Francis, IVVN board member and Managing Director of BioVacc Consulting Ltd, discusses vaccines against veterinary coronaviruses and how these could relate to the COVID-19 pandemic.
Dr Peera Jaru-Ampornpan and Dr Vanvimon Saksmerprome introduce BIOTEC, a research centre in Thailand, and discuss the veterinary vaccinology research that happens at the institute.
Band C (£27,355 to £29,083) or D (£32,684 to £35,104)
£62,727 to £131,538
£34,805 to £37,000
£32,684 to £35,104 / £39,974 to £43,432